# Junta clínica — PT-pseudo_e91d5fe837cb (tarea 1)

## Intervención 1 — INTAKE

*the record clerk; reads the file out loud and interprets nothing* · vuelta 1

Colleagues, this is the record as it arrived, field by field. I read it out and interpret nothing; everything after this is yours.

{
  "case_id": "PT-pseudo_e91d5fe837cb",
  "pid": "PT-pseudo_e91d5fe837cb",
  "task": 1,
  "psa": 6.1,
  "age": 63,
  "months": 1,
  "pirads": "4",
  "psad": 0.12,
  "psav": 0.89,
  "psap": 5.3,
  "vol": 50.0,
  "dre": "Nodus",
  "bx": "Positive",
  "cspca": 0.6372923,
  "medhx": "Hypercholesterolaemia, Chronic kidney disease, Benign prostatic hyperplasia",
  "meds": "atorvastatin, simvastatin, rosuvastatin, tamsulosin",
  "notes": "PSA 6.1 ng/mL. PI-RADS 4. PSAD 0.12. Prostate volume 50 mL. DRE nodus. csPCa 0.64.",
  "pmhx": [
    "Hypercholesterolaemia",
    "Chronic kidney disease",
    "Benign prostatic hyperplasia"
  ],
  "allergies": [],
  "vitals": {
    "weight": "77 kg",
    "height": "180 cm",
    "bmi": "23.8",
    "bp": "105/87 mmHg",
    "hr": "75 bpm",
    "smoking": "Ex-smoker (40 pack-yr, quit 2009)",
    "last_dental": "6 mo ago",
    "flu_vax": "Sep 2024"
  },
  "enc_dept": "Urology - outpatient",
  "enc_date": "18 Jan 2025",
  "enc_ref": "Dr. R. van den Berg (GP)",
  "enc_type": "Re-evaluation - prior PCa diagnosis",
  "note_sections": [
    {
      "s": "Chief complaint",
      "t": "Ongoing monitoring required due to previously confirmed malignancy and steadily climbing PSA levels."
    },
    {
      "s": "History",
      "t": "At age 63, this retired warehouse worker first entered clinical scrutiny for prostate irregularities toward the end of 2022. Medical background includes hypercholesterolaemia and chronic kidney disease, currently treated with atorvastatin, simvastatin, rosuvastatin, and tamsulosin. A 40 pack-year smoking history is noted, though cessation occurred back in 2009. Lower urinary tract complaints remain minimal, reflected by an IPSS score of 1/35, and he explicitly denies pelvic discomfort or blood in the urine. Marital status is divorced, and he resides independently, relying on his grown son as his main point of contact. Daily habits include roughly 20 units of alcohol per week, while physical activity consists mainly of routine gardening instead of formal workouts. Commuting to the facility takes over an hour by rail. Recent outpatient visits covered routine thyroid evaluations, a surveillance colonoscopy under gastroenterology, and a vascular surgery assessment for varicose veins. He reports no unexplained weight reduction, skeletal pain, or systemic complaints, with his primary focus remaining strictly on prostate surveillance."
    },
    {
      "s": "Physical examination",
      "t": "DRE — texture: moderately enlarged gland; right posterior peripheral zone contains a firm, discrete nodule; remainder presents as symmetrically smooth. General survey shows a well-nourished gentleman without signs of acute distress. Chest auscultation reveals clear breath sounds, and cardiovascular rhythm remains regular. Abdominal palpation yields a soft, non-tender cavity devoid of palpable masses or organ enlargement."
    }
  ],
  "occupation": "retired warehouse worker",
  "marital": "Divorced",
  "living": "Lives alone",
  "next_of_kin": "Adult son (primary contact)",
  "recent_other": [
    "Endocrine — thyroid screening",
    "Gastroenterology — surveillance colonoscopy",
    "Vascular surgery — varicose veins consult"
  ],
  "alcohol": "20 units / week",
  "exercise": "Gardening, no structured exercise",
  "ipss": "IPSS score: 1/35 (mild LUTS)",
  "admin": "Patient travels 60+ min by train to clinic; allow buffer.",
  "mri_hospital": "Maastricht UMC+",
  "ct": null,
  "active_treatment_flag": 0
}

## Intervención 2 — INTAKE

*the record clerk; reads the file out loud and interprets nothing* · vuelta 1

And this is the same record as the reading form presents it — the panel the urologist sees up front, with the masked documents named but not shown.

You are a senior urologist reviewing a patient case. The structured clinical
record below is shown to you up front, exactly as in the reading form. Some
documents are not shown and must be pulled up via the available tools
(radiology / MRI report, pathology report, previous notes, laboratory
results, PSA history, and the family-history anamnesis) when you need to
consult them.

Case ID: PT-pseudo_e91d5fe837cb
Task: 1

Encounter: Urology - outpatient on 18 Jan 2025.
Referrer: Dr. R. van den Berg (GP).
Type: Re-evaluation - prior PCa diagnosis.

Clinical data (read-only — values loaded from the record):
  - 63-year-old male
  - PSA: 6.1 ng/mL
  - mpMRI — PI-RADS score: 4 (1–2 low · 3 equivocal · 4–5 high risk)
  - PSA density: 0.12 ng/mL²
  - PSA velocity: 0.89 ng/mL/yr
  - Prior PSA: 5.3 ng/mL
  - Prostate volume: 50.0 mL
  - Months since last PSA: 1
  - DRE findings: Nodus (Normal · Nodus · Benign · Suspicious · Abnormal · Negative · Not done)
  - Prior biopsy: Positive (None · Negative · ASAP/HGPIN · Positive)
  - csPCa predicted probability: 0.6372923 (clinically significant PCa = ISUP ≥ 2)

Medical history & medication:
  - Medical history: Hypercholesterolaemia, Chronic kidney disease, Benign prostatic hyperplasia
  - Problem list / PMHx: Hypercholesterolaemia, Chronic kidney disease, Benign prostatic hyperplasia
  - Current medication: atorvastatin, simvastatin, rosuvastatin, tamsulosin
  - Allergies: NKA
  - Additional notes: PSA 6.1 ng/mL. PI-RADS 4. PSAD 0.12. Prostate volume 50 mL. DRE nodus. csPCa 0.64.

Vitals: weight 77 kg, height 180 cm, BMI 23.8, BP 105/87 mmHg, HR 75 bpm. Smoking: Ex-smoker (40 pack-yr, quit 2009).

Chief complaint: Ongoing monitoring required due to previously confirmed malignancy and steadily climbing PSA levels.

History: At age 63, this retired warehouse worker first entered clinical scrutiny for prostate irregularities toward the end of 2022. Medical background includes hypercholesterolaemia and chronic kidney disease, currently treated with atorvastatin, simvastatin, rosuvastatin, and tamsulosin. A 40 pack-year smoking history is noted, though cessation occurred back in 2009. Lower urinary tract complaints remain minimal, reflected by an IPSS score of 1/35, and he explicitly denies pelvic discomfort or blood in the urine. Marital status is divorced, and he resides independently, relying on his grown son as his main point of contact. Daily habits include roughly 20 units of alcohol per week, while physical activity consists mainly of routine gardening instead of formal workouts. Commuting to the facility takes over an hour by rail. Recent outpatient visits covered routine thyroid evaluations, a surveillance colonoscopy under gastroenterology, and a vascular surgery assessment for varicose veins. He reports no unexplained weight reduction, skeletal pain, or systemic complaints, with his primary focus remaining strictly on prostate surveillance.

Physical examination: DRE — texture: moderately enlarged gland; right posterior peripheral zone contains a firm, discrete nodule; remainder presents as symmetrically smooth. General survey shows a well-nourished gentleman without signs of acute distress. Chest auscultation reveals clear breath sounds, and cardiovascular rhythm remains regular. Abdominal palpation yields a soft, non-tender cavity devoid of palpable masses or organ enlargement.

Patient info: retired warehouse worker; Divorced; Lives alone.
Next of kin: Adult son (primary contact).

Lifestyle: alcohol 20 units / week; exercise Gardening, no structured exercise; IPSS score: 1/35 (mild LUTS).

Recent other appointments: Endocrine — thyroid screening; Gastroenterology — surveillance colonoscopy; Vascular surgery — varicose veins consult.
Admin: Patient travels 60+ min by train to clinic; allow buffer.

Information you can request via tools (the masked "Extended EHR view" — what
the urologist would actively pull up during the consult):
  - radiology / MRI report (full mpMRI prose behind the headline imaging values)
  - pathology report (any prior biopsy on record)
  - previous GP / urology consultation notes
  - laboratory results (full panel)
  - PSA history (trend / velocity beyond the headline value)
  - family history of prostate cancer (anamnesis)

Question:
Based on this patient's data, do you recommend biopsy?


One correction to that last paragraph before anybody acts on it: the documents this task actually serves are radiology_report, psa_trend, previous_notes, laboratory_results, plus the family-history anamnesis. There is NO pathology report to pull up in a task-1 biopsy decision — the prior-biopsy status on the panel above is all the pathology on record, and whatever the previous notes say about it. Nobody should ask for one, and nobody should quote one.

## Intervención 3 — EXPERT-STRUCTURED

*Expert 1, Extra-Trees on the structured panel only; opening bid with an error bar* · vuelta 1

Expert 1 here — the classifier that reads the structured panel and nothing else. My bid:

SUGGESTION: BIOPSY   p(biopsy) = 0.64
  uncertainty  +/- 0.07 epistemic (95% band 0.50-0.78); among patients I cannot tell apart the outcome was 0.94 of 1.00 mixed
  reliability  MODERATE ('supports' tier) — out-of-fold it was right 60% of the time over the 20 labelled cases in this tier

VARIABLES I WEIGHED — in the form's vocabulary, with this man's values (panel only; the levels are what moved my prediction across the series, not what a urologist would mark)
  decisive   prior biopsy = Positive (43% of my signal; from bx_positive, bx_none)
  important  comorbidity = 3 on the problem list (21% of my signal; from pmhx_hypercholesterolaemia, n_comorbidities)
  noted      age = 63 (2% of my signal; from age) · DRE = Nodus (10% of my signal; from dre_suspicious) · PSA = 6.1 ng/mL (3% of my signal; from log_psa, psav) · prostate volume = 50 mL (1% of my signal; from log_vol, vol) · PSA density = 0.12 (0% of my signal; from psad_calc, log_psad) · csPCa probability = 0.64 (1% of my signal; from cspca) · PI-RADS = 4 (20% of my signal; from pirads_ge4, pirads_ge3)
  not used   family history
CONFIDENCE: borderline — 'supports' tier; out-of-fold it was right 60% of the time over the 20 labelled cases in this tier

I read 39 raw variables, all from the panel — nothing from the mpMRI prose, the PSA
trajectory, the previous notes or the laboratory. Out-of-fold over 91 labelled cases: AUC
0.758, balanced accuracy 0.625.
The final call is the chair's.

## Intervención 4 — EXPERT-COHORT

*cohort criterion; what the labelled series did in this exact situation* · vuelta 1

This patient's situation: prior positive biopsy. The panel alone does not answer, and that is the finding.

The criterion here is that the visible panel does not determine this decision: he already has a tissue diagnosis, so neither a high PI-RADS nor a rising PSA is new information. What decides it is the documented grade of the prior biopsy and the surveillance history, which live in the previous notes. Measured on the labelled series: none of the three panel
rules I carry for this situation (PSA >= 20, age >= 78, PI-RADS <= 2) applies to him, and among the
39 remaining labelled men in this situation no structured variable separates the two answers.

REGISTRAR: the previous notes are where this case is decided. Read them for the grade of the prior
biopsy (Gleason or ISUP), the number of biopsy sessions and their dates, and whether he is on a
surveillance protocol with a confirmatory biopsy due. Do not read this as 'defer' and do not read it
as 'biopsy'.

VARIABLES I WEIGHED — in the form's vocabulary, with this man's values (panel only; 'decisive' marks the variable the rule turns on)
  important  prior biopsy = Positive
  noted      age = 63 · DRE = Nodus · PSA = 6.1 ng/mL · prostate volume = 50 mL · PSA density = 0.12 · PI-RADS = 4 · comorbidity = 3 on the problem list
  not used   family history, csPCa probability
CONFIDENCE: uncertain — none of my three panel rules applies; the fact that would settle it — the documented prior grade — lives in the notes, not on the panel

## Intervención 5 — EXPERT-LIBRARY

*case library; the closest labelled precedents and what the reading urologist did with them* · vuelta 1

The case library holds 49 labelled men in this same situation (Positive prior biopsy). The 3 closest by panel distance, and what the reading urologist did:
  1. distance 1.21: PI-RADS 4, PSA 13.2, PSAD 0.14, age 66, DRE Nodus -> BIOPSY (uncertain). He wrote: "There is no information on ISUP in the earlier cancer diagnosis and missing also size of earlier PIRADS 4 lesion"
  2. distance 1.23: PI-RADS 4, PSA 5.3, PSAD 0.1, age 56, DRE Nodus -> BIOPSY (clear). He wrote: "PIRADS 4 in a young man with a rapid increasing PSA"
  3. distance 1.33: PI-RADS 4, PSA 3.8, PSAD 0.126, age 70, DRE Nodus -> DEFER (borderline). He wrote: "stable MRi findings in 70yr with reasonably low PSA. prev biopsy finding without obvious indication for treatment. IF patient want to be very active in treatment, consid…"

PRECEDENT: BIOPSY (weighted vote 0.68 for biopsy). Distance-weighted precedent is no better than chance here (0.47 leave-one-out): read the precedents for how this urologist reasons, not for the answer.

What the precedents are FOR: they show what this urologist looks at and how he phrases the call. What they are NOT: facts about this patient. Nobody may cite a precedent's grade, PSA or MRI as if it were his.

WHAT THE READING UROLOGIST WEIGHED IN THESE PRECEDENTS — in the form's vocabulary, with this man's values (weighted majority of the 3 nearest labelled traces; the distance itself is on PI-RADS, prior biopsy first)
  important  prior biopsy = Positive · age = 63 · PSA = 6.1 ng/mL · PI-RADS = 4
  noted      family history = not opened (0 of 91) · DRE = Nodus · prostate volume = 50 mL · PSA density = 0.12 · comorbidity = 3 on the problem list
  not used   csPCa probability
CONFIDENCE: uncertain — in this situation the library is no better than chance (47% out of fold)

## Intervención 6 — EXPERT-TRACE

*Expert 4, trace model; which documents the reading urologist opens and what he weighs in this situation* · vuelta 1

Expert 4 here — the model of how the reading urologist works a case like this. Predicted from his 49 labelled traces in this situation (Positive prior biopsy): a per-field model where it beats the mode out of fold (prior-biopsy weight, DRE weight, PI-RADS weight, and whether he opens the laboratory), the mode elsewhere.

WHAT HE OPENS: radiology_report, psa_trend, previous_notes, laboratory_results.

WHAT HE WEIGHS — in the form's vocabulary, with this man's values (these are the levels that go on the form, unless a colleague shows a reason to move one)
  important  prior biopsy = Positive · age = 63 · DRE = Nodus · PSA = 6.1 ng/mL · PI-RADS = 4
  noted      family history = not opened (0 of 91) · prostate volume = 50 mL · PSA density = 0.12 · comorbidity = 3 on the problem list
  not used   csPCa probability
CONFIDENCE: clear — the level the reading urologist records in this situation, from his labelled traces

MODERATOR: that list of documents is the plan — exactly those, no more. Every document opened beyond what
he would open is scored against the conference as an unnecessary reveal; every document left closed
leaves a variable he weighed without its source. Attach the question each one must answer.

## Intervención 7 — EXPERT-EAU

*EAU guideline specialist; speaks only from the guideline text he retrieved* · vuelta 1

GUIDELINE
The retrieved guideline discusses using the PI-RADS score and PSA density to guide the decision to perform a biopsy. It states, "linking PI-RADS score (1-2, 3, and 4-5) to PSA-D categories (< 0.10, 0.10-0.15, 0.15-0.20ng/mL) (Table 5.5) [230]. This risk-adapted matrix table may guide the decision to perform a biopsy." This requires establishing the patient's PSA density to determine the appropriate risk stratification.

WHAT THE EXPERTS' BIDS DO NOT SETTLE
EXPERT-STRUCTURED, I note that the guideline makes the PSA density variable decisive for risk stratification, whereas EXPERT-STRUCTURED marked prior biopsy as decisive. The guideline suggests using PSA density to guide the decision, which is different from the expert's focus on the prior biopsy status. The guideline requires the PSA density value, which is a variable not represented by the prior biopsy status.

WHAT THE DOCUMENTS MUST SETTLE
previous_notes - the documented grade of the prior biopsy: at ISUP 2 or above the guideline sends him to treatment, not to more tissue; if it is unrecorded the indication stands
radiology_report - whether the lesion is compared against an earlier study: unchanged does not support re-sampling, new or larger does
psa_trend - the rate of PSA change: a rising PSA velocity is a factor in risk stratification, which the guideline uses to assess risk.
laboratory_results - the PSA density value: this value is required by the guideline to determine the risk category.

## Intervención 8 — MODERATOR

*chairs the discussion; sets the open questions and assigns the documents* · vuelta 1

This case hinges on establishing the documented grade of the prior biopsy and the PSA density to apply the EAU risk stratification matrix.

The documents for this session were fixed by EXPERT-TRACE; what I add is the question each one has to answer, and the open questions for the room.

REGISTRAR — pull these up, and answer exactly the question attached to each:
  radiology_report (get_mri_report) -> Does the lesion size or extraprostatic extension change compared to an earlier study?
  psa_trend (get_psa_trend) -> What is the rate of PSA change?
  previous_notes (get_previous_notes) -> What is the documented grade of the prior biopsy (Gleason or ISUP), the number and dates of biopsy sessions, and whether he is on a surveillance protocol with a confirmatory biopsy due?
  laboratory_results (get_lab_results) -> What is the PSA density value?

OPEN QUESTIONS for this conference — these are what the decision hangs on:
  Q1. What is the documented grade of the prior biopsy?

On the plan itself: Dropped 1 question(s) that asked for a value already printed on the panel: "What is the PSA density value?".

## Intervención 9 — REGISTRAR

*the registrar who pulls up documents; reports what they say, nothing else* · vuelta 1

WHAT I FOUND
radiology_report
Radiology Consultation | 10 January 2025 | Multiparametric MRI of the Prostate
COMPARISON: new
LESION: PI-RADS 4 lesion in the right posterior peripheral zone, spanning roughly 14 x 10 x 12 mm.

psa_trend
PSA trend shows a rising PSA velocity: PSA 2.9 (Oct 2022) rising to 6.1 (Jan 2025).

previous_notes
PRIOR GRADE: not recorded
BIOPSY SESSIONS: not recorded
SURVEILLANCE: outpatient visit arranged to perform a digital rectal examination alongside additional imaging studies. Immediate intervention was deemed unnecessary at that juncture.
TREATMENT: Immediate intervention was deemed unnecessary at that juncture.

laboratory_results
PSA density value is 0.12 ng/mL/mL.

WHAT I DID NOT OPEN
family-history anamnesis, as it was not required by the plan to answer the immediate questions.

WHAT THIS SUPPORTS
FOR sampling this patient now
PI-RADS 4 finding from the mpMRI report.
Rising PSA velocity from the PSA trend data.

AGAINST sampling this patient now
Prior biopsy status is not documented with a grade in the previous notes.

WHERE THIS LEANS
LEAN: unclear

## Intervención 10 — EXPERT-PSA

*Expert 2, PSA projector; the trajectory behind the headline PSA, with a conformal band* · vuelta 1

Expert 2 here — the PSA projector. I read only the serial PSA the registrar opened.

TRAJECTORY: RISING (borderline). Last value 6.10 ng/mL over 4 points spanning 27 months; velocity +1.43 ng/mL per year; doubling time about 25 months.
PROJECTION at 6 months: 7.7 ng/mL, conformal 95% band 2.2-26.9.

Read the band before the point: it is wide by construction, and I only call a direction when the whole
band clears the last value. This does not vote on the biopsy — a rising PSA in a man with a known
diagnosis is the disease behaving as known — it tells the chair how fast the number is moving.

VARIABLES I WEIGHED — in the form's vocabulary, with this man's values (the serial PSA only)
  noted      PSA = 6.1 ng/mL
  not used   prior biopsy, family history, age, DRE, prostate volume, PSA density, csPCa probability, PI-RADS, comorbidity
CONFIDENCE: borderline — the conformal band does not clear the last value

## Intervención 11 — EXPERT-FUSION

*Expert 3, Extra-Trees on panel + laboratory + MRI prose; speaks only on documents that were opened* · vuelta 1

Expert 3 here — the fusion classifier. I read the panel, the mpMRI report and the laboratory panel; nothing from the previous notes or the PSA series.

SUGGESTION: BIOPSY   p(biopsy) = 0.57
  uncertainty  +/- 0.09 epistemic (95% band 0.40-0.74), of which 0.00 comes from values that had to be imputed
  reliability  LOW ('discuss' tier) — out-of-fold it was right 61% of the time over the 31 labelled cases in this tier

VARIABLES I WEIGHED — in the form's vocabulary, with this man's values (panel + the documents that were opened; PI-RADS here means the report's own wording — DWI restriction, lesion size — not the score)
  decisive   prior biopsy = Positive (43% of my signal; from bx_positive, bx_none)
  important  PI-RADS = 4 (22% of my signal; from rad_dwi_restriction, rad_lesion_ge15mm)
  noted      DRE = Nodus (5% of my signal; from dre_suspicious) · PSA = 6.1 ng/mL (21% of my signal; from fpsa_lt15, psa_delta_prev) · prostate volume = 50 mL (4% of my signal; from log_vol, vol) · PSA density = 0.12 (0% of my signal; from psad_calc) · comorbidity = 3 on the problem list (4% of my signal; from n_comorbidities, on_alpha_blocker)
  not used   family history, age, csPCa probability
CONFIDENCE: uncertain — 'discuss' tier; out-of-fold it was right 61% of the time over the 31 labelled cases in this tier

Out-of-fold AUC 0.794. I am the only expert that has read the report's
wording, and I still cannot see the prior grade or the surveillance history: those are in the notes, and
the registrar has to carry them.

## Intervención 12 — PANEL-PROTOCOL

*the panel's written protocol; consolidates the experts by rule and says which rule fired* · vuelta 1

The panel protocol, applied to what is on the board:

  EXPERT-STRUCTURED  BIOPSY, p(biopsy)=0.64  ('supports' tier; weight 2.0)
  EXPERT-FUSION      BIOPSY, p(biopsy)=0.57  ('discuss' tier, fusion_full; weight 1.5)
  EXPERT-LIBRARY     BIOPSY, p(biopsy)=0.68  (k=3 precedents; does not vote)

  documented prior grade in the opened documents: none recorded

RULE THAT FIRED: weighted vote of the trained experts, p = 0.61 — carried by weighted panel.
PANEL ANSWER: BIOPSY. EXPERT-STRUCTURED carried the most weight ('supports' tier). In this bucket no rule applied and the documents did not record the prior grade, so the trained experts decide.

THE BOARD'S VARIABLES — value · what each expert marked · what goes on the form
  bx           Positive                     E1:DEC E3:DEC cohort:IMP library:IMP E2:—            -> important
  fh           not opened (0 of 91)         E1:— E3:— cohort:— library:not E2:—                  -> not_used (raised from noted by the board)
  age          63                           E1:not E3:— cohort:not library:IMP E2:—              -> important
  dre          Nodus                        E1:not E3:not cohort:not library:not E2:—            -> important
  psa          6.1 ng/mL                    E1:not E3:not cohort:not library:IMP E2:not          -> important
  vol          50 mL                        E1:not E3:not cohort:not library:not E2:—            -> noted
  psad         0.12                         E1:not E3:not cohort:not library:not E2:—            -> noted
  cspca        0.64                         E1:not E3:— cohort:— library:— E2:—                  -> not_used
  pirads       4                            E1:not E3:IMP cohort:not library:IMP E2:—            -> important
  comorbidity  3 on the problem list        E1:IMP E3:not cohort:not library:not E2:—            -> noted
  (DEC decisive · IMP important · not noted · — not used; the last column is the level recorded, from the trace of the reading urologist)

Confidence to record: clear.

CHAIR: this is the panel's position. You sign it, and you write why in the room's words — naming what the registrar retrieved. If you believe a retrieved finding overturns it, name that finding with its value; the burden is on the finding, not on the panel.

## Intervención 13 — VERIFIER

*second EAU reader; checks against the guideline whether this can be decided yet* · vuelta 1

SUFFICIENCY
The documents the registrar opened (radiology_report, psa_trend, previous_notes, laboratory_results) did not answer the moderator's question regarding the documented grade of the prior biopsy.

ALIGNMENT WITH THE PANEL
The PANEL-PROTOCOL concluded BIOPSY based on a weighted vote of the experts, noting that the "documented prior grade in the opened documents: none recorded." This aligns with the finding that the prior biopsy status was not documented in the retrieved notes.

THE OPEN QUESTIONS, ONE BY ONE
Q1. What is the documented grade of the prior biopsy? This question remains unanswered because the `previous_notes` explicitly stated "PRIOR GRADE: not recorded."

WHAT CARRIES WEIGHT, AND WHY
prior biopsy: Positive (noted) because the EXPERT-STRUCTURED and EXPERT-FUSION models weighted this as important, and the EXPERT-LIBRARY precedent also weighted it as important. I would move this to 'decisive' if the notes had contained a grade, but since it is not recorded, the panel's reliance on expert consensus is justified. My confidence in the record as it stands is clear, as the trace model opened all relevant documents.

MY SUGGESTION TO THE CHAIR
The panel's decision to recommend BIOPSY is supported by the weighted consensus of the experts, despite the missing documentation of the prior biopsy grade.

VERDICT: ready | SUGGEST: biopsy | MISSING: none

[The conference closes after pass 1: the verifier called the record ready. The chair decides on the record as it stands.]

## Intervención 14 — CHAIR

*the senior urologist who signs the decision* · vuelta 1

MY DECISION: BIOPSY   (confidence: clear)

63y/o, PSA 6.1, PSAD 0.12, PI-RADS 4, prior biopsy positive but grade not recorded. The lack of prior grade mandates sampling to determine management. The rising PSA velocity and new PI-RADS 4 lesion drive the need for tissue diagnosis. Biopsy recommended.

What carried weight: bx=important, age=important, dre=important, psa=important, vol=noted, psad=noted, pirads=important, comorbidity=noted
Sections retrieved: radiology_report, psa_trend, previous_notes, laboratory_results
